Aldeyra Therapeutics, Inc.ALDXNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-0.72
Operating CF/Share$-0.67
Free CF/Share$-0.67
Cash/Share$1.25
Book Value/Share$0.82
Tangible Book/Share$0.82
Equity/Share$0.82
Interest Debt/Share$0.29
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$328.49M
Enterprise Value$284.69M
P/E Ratio-7.60P/S Ratio0.00P/OCF Ratio-8.19
P/FCF Ratio-8.20
P/B Ratio6.67P/TB Ratio6.67
EV/Sales0.00EV/EBITDA-6.94
Graham Valuation
Graham Number--
Graham Net-Net$0.78
Profitability
Earnings Yield-13.16%FCF Yield-12.20%ROE-72.25%ROIC-69.73%Return on Tangible Assets-55.52%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.32Debt/Assets0.20Debt/Market Cap0.05
Net Debt/EBITDA1.07
Current Ratio2.72Interest Coverage-23.76xIncome Quality0.93Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding76 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover4.80x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$49.24M
Working Capital$48.98M
Invested Capital$49.32M
Intangibles/Assets0.00%